ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Supernus’ stocks down once more, despite positive phase 3 ADHD data for SPN-812
December 29, 2018Supernus Pharmaceuticals unveiled topline results from two phase 3 studies of children with attention deficit hyperactivity disorder but failed to wow investors worried about how its nonstimulant treatment would take on already-established generics.....
Pharma Sources Insight January 2025
